TipRanks
Advertisement
Advertisement

DE:6C1 Stock Latest News

CytomX Therapeutics gets Fast Track Designation for Varseta-M
The FlyCytomX Therapeutics gets Fast Track Designation for Varseta-M
1M ago
CTMX
CytomX Therapeutics price target lowered to $11 from $12 at JPMorgan
PremiumThe Fly
CytomX Therapeutics price target lowered to $11 from $12 at JPMorgan
2M ago
CTMX
CytomX Therapeutics price target lowered to $14 from $15 at Guggenheim
PremiumThe Fly
CytomX Therapeutics price target lowered to $14 from $15 at Guggenheim
2M ago
CTMX
CytomX Therapeutics reports Q2 EPS (9c), consensus (10c)
PremiumThe Fly
CytomX Therapeutics reports Q2 EPS (9c), consensus (10c)
2M ago
CTMX
CTMX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
CTMX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
2M ago
CTMX
CytomX Therapeutics appoints Alejandra Carvajal as chief legal officer
PremiumThe FlyCytomX Therapeutics appoints Alejandra Carvajal as chief legal officer
2M ago
CTMX
CytomX Therapeutics Adds Dr. Fuchs to Board
Premium
Company Announcements
CytomX Therapeutics Adds Dr. Fuchs to Board
2M ago
8K
CTMX
Citizens healthcare analysts hold an analyst/industry conference call
Premium
The Fly
Citizens healthcare analysts hold an analyst/industry conference call
3M ago
CTMX
EXEL
CytomX Shareholders Approve Expanded Equity and Capital Plans
PremiumCompany Announcements
CytomX Shareholders Approve Expanded Equity and Capital Plans
4M ago
8K
CTMX
CytomX Expands High-Value Bispecific Cancer Partnership With Regeneron
PremiumCompany Announcements
CytomX Expands High-Value Bispecific Cancer Partnership With Regeneron
4M ago
8K
CTMX
CytomX Therapeutics expands licensing agreement with Regeneron
PremiumThe Fly
CytomX Therapeutics expands licensing agreement with Regeneron
4M ago
CTMX
REGN
CytomX Earnings Call: Varseta‑M Drives Long Runway
PremiumCompany Announcements
CytomX Earnings Call: Varseta‑M Drives Long Runway
5M ago
CTMX
CytomX Therapeutics initiated with an Outperform at Wolfe Research
PremiumThe FlyCytomX Therapeutics initiated with an Outperform at Wolfe Research
5M ago
CTMX
CytomX Therapeutics price target lowered to $11 from $17 at H.C. Wainwright
Premium
The Fly
CytomX Therapeutics price target lowered to $11 from $17 at H.C. Wainwright
5M ago
CTMX
CytomX Therapeutics: Early-Stage Pipeline, Trial Setbacks and High Risks on the Road to Profitability
Premium
Company Announcements
CytomX Therapeutics: Early-Stage Pipeline, Trial Setbacks and High Risks on the Road to Profitability
5M ago
CTMX
CytomX Earnings Call Highlights Varseta-M Momentum
PremiumCompany Announcements
CytomX Earnings Call Highlights Varseta-M Momentum
5M ago
CTMX
CytomX Therapeutics reports Q1 EPS (10c), consensus (11c)
PremiumThe Fly
CytomX Therapeutics reports Q1 EPS (10c), consensus (11c)
5M ago
CTMX
CytomX Therapeutics participates in a conference call with JPMorgan
PremiumThe Fly
CytomX Therapeutics participates in a conference call with JPMorgan
6M ago
CTMX
CytomX Therapeutics Signals Progress in Varseta-M Trial
PremiumCompany Announcements
CytomX Therapeutics Signals Progress in Varseta-M Trial
6M ago
CTMX
CytomX Therapeutics price target raised to $12 from $10 at Piper Sandler
PremiumThe FlyCytomX Therapeutics price target raised to $12 from $10 at Piper Sandler
7M ago
CTMX
CytomX Therapeutics Raises $234 Million in Equity Offering
Premium
Company Announcements
CytomX Therapeutics Raises $234 Million in Equity Offering
7M ago
8K
CTMX
CytomX Therapeutics price target raised to $16 from $10 at Barclays
Premium
The Fly
CytomX Therapeutics price target raised to $16 from $10 at Barclays
7M ago
CTMX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >